PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| INBX | Eckelman Brendan P. | Chief Scientific Officer | May 28 '24 | Sale | 34.30 | 300,000 | 10,290,000 | 1,735,553 | May 30 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | May 22 '24 | Option Exercise | 28.48 | 5,010 | 142,661 | 26,667 | May 24 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 13 '24 | Option Exercise | 33.63 | 1,898 | 63,830 | 9,177 | Mar 15 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 12 '24 | Option Exercise | 31.85 | 24,050 | 765,912 | 29,167 | Mar 12 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 11 '24 | Option Exercise | 28.54 | 13,558 | 386,941 | 33,319 | Mar 12 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 08 '24 | Option Exercise | 33.63 | 2,150 | 72,305 | 37,850 | Mar 12 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 01 '23 | Sale | 24.21 | 40,000 | 968,231 | 2,035,553 | Mar 02 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Feb 02 '23 | Sale | 25.45 | 11,250 | 286,355 | 2,075,553 | Feb 02 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Feb 01 '23 | Sale | 24.73 | 28,750 | 710,856 | 2,086,803 | Feb 02 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Jan 04 '23 | Sale | 23.48 | 7,105 | 166,829 | 2,115,553 | Jan 04 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Jan 03 '23 | Sale | 23.77 | 32,895 | 781,770 | 2,122,658 | Jan 04 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Dec 06 '22 | Sale | 27.22 | 40,000 | 1,088,682 | 2,155,553 | Dec 07 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Nov 01 '22 | Sale | 33.51 | 40,000 | 1,340,387 | 2,195,553 | Nov 02 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Oct 04 '22 | Sale | 27.82 | 40,000 | 1,112,813 | 2,235,553 | Oct 05 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Sep 06 '22 | Sale | 14.91 | 40,000 | 596,273 | 2,435,553 | Sep 07 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Aug 03 '22 | Sale | 18.47 | 15,500 | 286,209 | 2,475,553 | Aug 04 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Aug 02 '22 | Sale | 17.70 | 24,500 | 433,626 | 2,491,053 | Aug 04 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Jul 07 '22 | Sale | 17.17 | 40,000 | 686,800 | 2,515,553 | Jul 08 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Apr 05 '22 | Sale | 25.04 | 400 | 10,016 | 2,555,553 | Apr 07 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Mar 24 '21 | Sale | 19.02 | 17,000 | 323,340 | 2,555,953 | Mar 24 |
| INBX | Eckelman Brendan P. | Chief Scientific Officer | Feb 16 '21 | Sale | 25.90 | 17,000 | 440,300 | 2,572,953 | Feb 18 |